| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | For external use |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Valproate sodium injection | |
| contians | Valproate sodium 500mg | |
| Package | 5ml*5amps/box*20boxs/carton | |
| Store | Refrigerate powder at 20° to 25°C (68° to 77°F) | |
| Shelf lift | 36 month | |
| application |
Valproate Sodium Injection, USP is indicated as an intravenous alternative in patients for whom oral administration of valproate products is temporarily not feasible in the following conditions: Valproate Sodium Injection, USP is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproate Sodium Injection, USP is also indicated for use as sole and adjunctive therapy in the treatment of patients with simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. |
|
){kind=link}